Wenying Lu

1.2k total citations
29 papers, 885 citations indexed

About

Wenying Lu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Wenying Lu has authored 29 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Wenying Lu's work include MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (4 papers). Wenying Lu is often cited by papers focused on MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers) and Circular RNAs in diseases (4 papers). Wenying Lu collaborates with scholars based in China, Australia and Canada. Wenying Lu's co-authors include Anquan Shang, Weiwei Wang, Chenzheng Gu, Zujun Sun, Bingjie Zeng, Chen Chen, Junlu Wu, Yibao Yang, Dong Li and Ping Ji and has published in prestigious journals such as Frontiers in Immunology, The American Journal of Gastroenterology and RSC Advances.

In The Last Decade

Wenying Lu

29 papers receiving 875 citations

Peers

Wenying Lu
Chaohui Zuo China
Teruyuki Ueda Japan
Caecilia Sukowati Italy
Claudia Montaldo Italy
Xiaomin Ma China
Jinpiao Lin China
Yajin Chen China
Benjamin Ruf United States
Guobin Wu China
Zhongming Tan China
Chaohui Zuo China
Wenying Lu
Citations per year, relative to Wenying Lu Wenying Lu (= 1×) peers Chaohui Zuo

Countries citing papers authored by Wenying Lu

Since Specialization
Citations

This map shows the geographic impact of Wenying Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenying Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenying Lu more than expected).

Fields of papers citing papers by Wenying Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenying Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenying Lu. The network helps show where Wenying Lu may publish in the future.

Co-authorship network of co-authors of Wenying Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenying Lu. A scholar is included among the top collaborators of Wenying Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenying Lu. Wenying Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Weiwei, et al.. (2021). Lipopolysaccharides increase the risk of colorectal cancer recurrence and metastasis due to the induction of neutrophil extracellular traps after curative resection. Journal of Cancer Research and Clinical Oncology. 147(9). 2609–2619. 30 indexed citations
3.
4.
Pan, Hongchao, Weiyong Wang, Wei Chen, et al.. (2020). Everestmab, a novel long-acting GLP-1/anti GLP-1R nanobody fusion protein, exerts potent anti-diabetic effects. Artificial Cells Nanomedicine and Biotechnology. 48(1). 854–866. 8 indexed citations
5.
Shang, Anquan, Chenzheng Gu, Chen Zhou, et al.. (2020). Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression. Cell Communication and Signaling. 18(1). 52–52. 100 indexed citations
6.
Wang, Weiwei, et al.. (2020). Design and biological evaluation of novel BF-30 analogs for the treatment of malignant melanoma. Journal of Cancer. 11(24). 7184–7195. 6 indexed citations
7.
Shang, Anquan, Weiwei Wang, Chenzheng Gu, et al.. (2020). Correction to: Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils. Journal of Experimental & Clinical Cancer Research. 39(1). 3 indexed citations
8.
Shang, Anquan, Weiwei Wang, Chenzheng Gu, et al.. (2020). Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression. Aging. 12(9). 8301–8320. 41 indexed citations
9.
Shang, Anquan, Weiwei Wang, Chenzheng Gu, et al.. (2019). Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils. Journal of Experimental & Clinical Cancer Research. 38(1). 272–272. 160 indexed citations
10.
Pan, Hongchao, et al.. (2019). Engineering an enhanced thrombin-based GLP-1 analog with long-lasting glucose-lowering and efficient weight reduction. RSC Advances. 9(53). 30707–30714. 2 indexed citations
11.
Jia, Qi, et al.. (2018). Mechanism of miR‐137 regulating migration and invasion of melanoma cells by targeting PIK3R3 gene. Journal of Cellular Biochemistry. 120(5). 8393–8400. 13 indexed citations
12.
Shang, Anquan, Cheng Zhou, Wei Chen, et al.. (2018). miR‐381‐3p restrains cervical cancer progression by downregulating FGF7. Journal of Cellular Biochemistry. 120(1). 778–789. 50 indexed citations
13.
Shang, Anquan, Wenying Lu, Man Yang, et al.. (2017). miR-9 induces cell arrest and apoptosis of oral squamous cell carcinoma via CDK 4/6 pathway. Artificial Cells Nanomedicine and Biotechnology. 46(8). 1–9. 32 indexed citations
14.
Wang, Weiwei, Fujun Shen, Chunlei Wang, et al.. (2017). MiR-1-3p inhibits the proliferation and invasion of bladder cancer cells by suppressing CCL2 expression. Tumor Biology. 39(6). 3726131438–3726131438. 32 indexed citations
15.
Wu, Jian, et al.. (2015). Inhibitory Effect of Curcumin on Invasion of Skin Squamous Cell Carcinoma A431 Cells. Asian Pacific Journal of Cancer Prevention. 16(7). 2813–2818. 24 indexed citations
16.
Wu, Jian, et al.. (2012). Clinical significance of STAT3 and MAPK phosphorylation, and the protein expression of cyclin D1 in skin squamous cell carcinoma tissues. Molecular Medicine Reports. 12(6). 8129–8134. 23 indexed citations
17.
Xie, Jiaxin, Jianhua Yin, Qi Zhang, et al.. (2012). [Association of genetic polymorphisms of key molecules in JAK/STAT signaling pathway with susceptibility of hepatocellular carcinoma].. PubMed. 33(2). 215–9. 5 indexed citations
18.
19.
Yin, Jianhua, Jiaxin Xie, Hongwei Zhang, et al.. (2010). Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. Journal of Gastroenterology. 45(10). 1063–1071. 52 indexed citations
20.
Yin, Jianhua, Jiaxin Xie, Shijian Liu, et al.. (2010). Association Between the Various Mutations in Viral Core Promoter Region to Different Stages of Hepatitis B, Ranging of Asymptomatic Carrier State to Hepatocellular Carcinoma. The American Journal of Gastroenterology. 106(1). 81–92. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chaohui Zuo Breakdown of academic impact, for papers by Teruyuki Ueda Breakdown of academic impact, for papers by Caecilia Sukowati Breakdown of academic impact, for papers by Claudia Montaldo Breakdown of academic impact, for papers by Xiaomin Ma Breakdown of academic impact, for papers by Jinpiao Lin Breakdown of academic impact, for papers by Yajin Chen Breakdown of academic impact, for papers by Benjamin Ruf Breakdown of academic impact, for papers by Guobin Wu Breakdown of academic impact, for papers by Zhongming Tan
Rankless by CCL
2026